Auxilium merges with Canadian biotech in tax-inversion effort

Share this article:

Auxilium stated today it will merge with Canadian biotechnology company QLT. Under the agreement, QLT will now be known as “New Auxilium.” The new leadership team will include two current QLT directors, although the company stated that it “does not expect any material changes to its current US operations or employment as a result of this transaction.” QLT is based out of Vancouver, and as such the newly combined company will take advantage of Canada's lower corporate tax rate, in what the New York Times called “one of the smallest inversions in recent years.” Auxilium's new tax rate is believed to be in the mid-20% range, according to the NYT.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters